Nanobot Algorithms for Treatment of Diffuse Cancer
Noble Harasha, Nancy Lynch · 2025
Read Nanobot Algorithms for Treatment of Diffuse Cancer by Noble Harasha, Nancy Lynch (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2509-06893.txt.
Introduction
Swarms of drug-carrying nanobots treating cancer spread across many sites are modeled by Noble Harasha and one co-author in a 2025 theoretical paper. Nanobots promise targeted delivery with less toxicity, but diffuse cancer presents several distinct sites at once. Payloads must be divided among sites according to need, which requires coordination.
A mathematical model describes the agents and their chemical environment, with movement based on experimental findings: the bots noisily climb and descend chemical gradients. Three algorithms are compared. The first simply follows natural chemical signals around each site and works unless signals are weak. The second amplifies those signals, speeding treatment but lowering eventual success except for concentrated cancers. The third also releases a counter-signal that repels bots from sites already treated enough. Simulations show the third algorithm performing well across all cancer patterns tested.
Catalog record
| CREATOR | Noble Harasha, Nancy Lynch |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 117 KB |
| VERSION | 1.0 |
| LICENSE | http://creativecommons.org/licenses/by/4.0/ |
| RIGHTS | CC BY |
| SOURCE | arXiv |
Source: https://arxiv.org/abs/2509-06893
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Nanobot Algorithms for Treatment of Diffuse Cancer Noble Harasha, Nancy Lynch Abstract The application of motile nanosized particles—also referred to as “nanobots”—for targeted drug delivery in the human body promises both more effective as well as less toxic treatment because of the particles’ unique scale and accompanying potential for precision. We consider the case in which the cancer is “diffuse”, that is, dispersed in a region such that there are multiple distinct and separate cancer sites in need of treatment. We investigate the problem of a swarm of identical nanobots locating these sites and treating the cancer by dropping drug payloads at the sites. Each cancer site also has its own unique “demand”, which represents how much of the cancer-treating drug it requires in order to be killed. To improve the success of the treatment, the drug payloads must be allocated between sites according to their demands; this requires extra nanobot coordination. We assume a finite lifetime for nanobots; consequently, the speed of the treatment is also a factor in the actual achieved level of success. We present a mathematical model of the behavior of the nanobot agents and of the dynamic chemical makeup of the colloidal environment through which the nanobots navigate. The general model includes a movement model for agents based upon experimental findings from actual nanoparticles in which bots noisily ascend or descend chemical gradients, depending on the type of chemical. We present three algorithms which describe additional chemical payloads that agents may carry onboard, beyond the cancer-treating drug which we call chemical K, as well as the rules for when agents drop these payloads. The first algorithm, called KM, is the most representative of reality, with agents simply following naturally existing chemical marker signals—which we call chemical M—that locally surround each cancer site. The second algorithm, KMA, includes an additional chemical payload—chemical A—which boosts, or amplifies, the existing natural signals. The third and most sophisticated algorithm, KMAR, includes another additional chemical payload—chemical R—which counteracts the other signals, instead inducing negative chemotaxis in agents such that they are repelled from sites that are already sufficiently treated. For all of the algorithms, we present simulation results for a variety of distinct cancer patterns, i.e., different arrangements of how the diffuse cancer is spread about the space. For the first algorithm KM, we show that the treatment is generally successful unless the natural chemical signals are weak, in which case the treatment progresses too slowly. For the second algorithm KMA, we demonstrate a significant improvement in the speed of the treatment but a drop in eventual success, except for the most concentrated cancer patterns in which the algorithm performs very well in both speed and success. For the third algorithm KMAR, our results show great performance across all types of cancer patterns, demonstrating robustness and adaptability in the algorithms’ novel mechanisms for nanobot coordination. 1 Introduction Motile nanoparticles suspended in a solution, or what are often referred to as “nanobots”, possess uniquely great potential in various medical applications—as a result of their unique scale—including penetrating biological barriers, navigating within otherwise unreachable regions of the body, and generally increased precision. Nanobots are being engineered to move within the human body, and more specifically, to navigate to locate target sites of interest, such as a cluster of cancerous cells. If such nanobots possess a payload of drugs onboard, they can presumably release the drugs once they locate and reach the given target site(s), providing a more selective and precise drug delivery solution that is less toxic to extraneous regions. In the context of cancer detection and treatment for example, as will be the focus in this paper, this “targeted drug delivery” solution presents a particularly dramatic decrease in side effects in comparison to existing treatments such as chemotherapy. However, as a consequence of nanobots’ very small size, their capabilities in sensing, locomotion, and computation are limited, noisy, and/or nonexistent, presenting challenges to this otherwise promising approach. We investigate the problem of nanobots finding and treating a number of cancerous sites, distributively and autonomously . In this work, we consider the process to be stochastic in nature, with nanobots performing a biased random walk, influenced by the chemical makeup and physics of the environment through which they navigate. The presence of multiple, distinct cancerous sites (as opposed to just a single site, as we investigated in [ 9 ] ), which are diffuse throughout the given environment in varied arrangements, introduces the problem of optimally allocating the treatment; e.g., avoiding sending all of the nanobots to a single, specific cancerous site, leaving the other sites completely untreated. In Section 2 , we give a formal, mathematical description of the general model of the nanobot agents and their colloidal environment, including a model of agent locomotion in which agents follow chemical signals by noisily ascending and descending their gradients. Working within this model, in Section 3 , we present three distinct algorithms which describe which additional chemical payloads (beyond a cancer-treating drug) agents carry “onboard”, as well as the rules for when they release such payloads. We then present simulation results for all of the algorithms in Section 4 , investigating the effectiveness and efficiency of the treatment strategies across different arrangements of cancer sites (e.g., all of the sites spread out versus some sites clustered near each other, two sites both requiring of equal amounts of treatment versus one of the two sites requiring of much more treatment, etc.) as well as for various parameter value settings. The three algorithms are increasingly complex: The first algorithm, which we call Algorithm KM, involves agents simply following naturally existing chemical signals centered around each cancer site. The second algorithm, KMA, involves agents dropping an additional chemical payload at cancer sites in order to amplify the existing natural signals. The final algorithm, KMAR, involves agents dropping a different chemical payload if they detect that a given cancer site has already received a sufficient amount of treatment; besides this additional, unique mechanism KMAR is the same as KMA. This different chemical payload serves to repel agents from moving towards the already treated site, instead encouraging them to explore elsewhere and locate other sites that are in need of treatment. Results show that Algorithm KM has generally successful treatment but can be slow if the endogenous chemical signals are weak. Algorithm KMA provides a significant improvement in efficiency over KM due to its amplified chemical signals, but for certain cancer site arrangements has unsuccessful treatment due to the amplification mechanism too strongly favoring a single site, leaving the others untreated. Algorithm KMAR’s added mechanism of dynamically favoring the chemical signals towards cancer sites still needing treatment helps to fix the above issues with KMA, while still preserving much of KMA’s efficiency with artificially amplified chemical signals. Ultimately, KMAR provides an effective and efficient treatment solution that performs well across all settings. However, we acknowledge that KMAR is the most sophisticated of the algorithms and is thus arguably the most speculative on the level of implementation with current nanotechnologies. Beyond the comparative advantages and disadvantages between the three algorithms, our results also show the impact of the specific arrangement or pattern of cancer in space on performance. For